×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NASDAQ:RPHM

Reneo Pharmaceuticals News Headlines

$2.25
-0.06 (-2.60%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.19
$2.36
50-Day Range
$1.96
$2.51
52-Week Range
$1.92
$11.40
Volume
1.02 million shs
Average Volume
56,983 shs
Market Capitalization
$55.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.80
Get Reneo Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter.

RPHM Media Mentions By Week

RPHM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RPHM
News Sentiment

1.10

0.39

Average
Medical
News Sentiment

RPHM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RPHM Articles
This Week

1

0

RPHM Articles
Average Week



RPHM Stock News Headlines Today

SourceHeadline
finance.yahoo.com logoIs Reneo Pharmaceuticals (NASDAQ:RPHM) In A Good Position To Invest In Growth?
finance.yahoo.com - June 20 at 10:08 AM
seekingalpha.com logoReneo Pharmaceuticals GAAP EPS of -$0.53 misses by $0.01
seekingalpha.com - May 10 at 10:05 PM
finance.yahoo.com logoReneo Pharmaceuticals Reports First Quarter 2022 Financial Results
finance.yahoo.com - May 10 at 5:05 PM
seekingalpha.com logoReneo Pharmaceuticals GAAP EPS of -$0.43 beats by $0.14
seekingalpha.com - March 23 at 9:53 PM
finance.yahoo.com logoReneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - March 23 at 4:53 PM
seekingalpha.com logoReneo Pharmaceuticals promotes Michael Cruse to COO role
seekingalpha.com - March 7 at 12:48 PM
finance.yahoo.com logoReneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare Conference
finance.yahoo.com - February 2 at 10:42 AM
finance.yahoo.com logoReneo Pharmaceuticals Announces Changes to its Board of Directors
finance.yahoo.com - January 24 at 4:17 PM
nasdaq.com logoWe Think Reneo Pharmaceuticals (NASDAQ:RPHM) Can Afford To Drive Business Growth
nasdaq.com - January 10 at 2:25 PM
nasdaq.com logoReneo Pharmaceuticals Inc Shares Close the Day 13.0% Higher - Daily Wrap
nasdaq.com - December 24 at 8:15 AM
benzinga.com logoCathie Wood Sells $8.6M Worth Shares In Pfizer, Buys Coinbase And Robinhood On The Dip
benzinga.com - December 16 at 11:43 PM
finance.yahoo.com logoReneo Pharmaceuticals Reports Third Quarter 2021 Financial Results
finance.yahoo.com - November 11 at 5:00 PM
benzinga.com logoReneo Pharmaceuticals to Participate at Upcoming Investor Conferences
benzinga.com - November 1 at 4:14 PM
finance.yahoo.com logoReneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001
finance.yahoo.com - October 14 at 9:16 AM
finance.yahoo.com logoHere's What Reneo Pharmaceuticals, Inc.'s (NASDAQ:RPHM) Shareholder Ownership Structure Looks Like
finance.yahoo.com - October 11 at 3:20 PM
finance.yahoo.com logoReneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer
finance.yahoo.com - October 11 at 8:48 AM
nasdaq.com logoA Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) insider lowered their holding by 100% earlier this year
nasdaq.com - September 10 at 3:42 PM
benzinga.com logoReneo Pharmaceuticals to Participate in Upcoming Investor Conferences
benzinga.com - September 9 at 9:21 AM
finance.yahoo.com logoReneo Pharmaceuticals Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 11 at 8:40 AM
seekingalpha.com logoDosing underway in Reneo Pharma's mid-stage STRIDE study
seekingalpha.com - July 30 at 11:09 PM
finance.yahoo.com logoReneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study
finance.yahoo.com - July 28 at 8:23 AM
barrons.com logoReneo Pharmaceuticals Inc.
barrons.com - July 18 at 7:24 PM
nasdaq.com logoFriday 7/16 Insider Buying Report: RPHM, CAG
nasdaq.com - July 16 at 2:26 PM
finance.yahoo.com logoWe're Not Very Worried About Reneo Pharmaceuticals' (NASDAQ:RPHM) Cash Burn Rate
finance.yahoo.com - July 12 at 4:34 PM
finance.yahoo.com logoReneo Pharmaceuticals Announces Partial Waiver of Lock-Up Restriction
finance.yahoo.com - July 9 at 12:32 PM
finance.yahoo.com logoReneo Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference
finance.yahoo.com - July 7 at 12:32 PM
finance.yahoo.com logoReneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
finance.yahoo.com - June 29 at 10:02 AM
nasdaq.com logoWednesday 6/23 Insider Buying Report: RPHM, SEAC
nasdaq.com - June 23 at 4:57 PM
nasdaq.com logoReneo Pharmaceuticals, Inc. Common Stock (RPHM)
nasdaq.com - June 17 at 12:23 AM
bizjournals.com logo'Overboarding' trend topples BioMarin director's re-election bid
bizjournals.com - June 3 at 6:53 PM
nasdaq.com logoTuesday 6/1 Insider Buying Report: BLDE, RPHM
nasdaq.com - June 1 at 7:45 PM
finance.yahoo.com logoReneo Pharmaceuticals Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 20 at 8:20 AM
in.finance.yahoo.com logoReneo Pharmaceuticals, Inc. (RPHM)
in.finance.yahoo.com - April 15 at 8:23 PM
reuters.com logoReneo Pharmaceuticals Inc
reuters.com - April 15 at 10:22 AM
Get Reneo Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPHM and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:RPHM) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.